AI Science Tracker
EN

Leeds Teaching Hospitals NHS Trust

1 discovery from 2022

Discoveries

PET/CT radiomics predicted two-year outcomes in Hodgkin lymphoma

Source check: Source checked. Not independent scientific confirmation.

Finding: In 289 patients with classical Hodgkin lymphoma, pretreatment PET/CT radiomics models predicted two-year event-free survival. The best ridge model had mean test AUC 0.81 (±0.12), with no significant advantage over a clinical/metabolic-tumour-volume logistic model. The retrospective single-institution study does not establish clinical utility; the first located result-bearing public version is the 2022-08-25 journal article.

Technology: Seven machine-learning models on FDG PET/CT radiomics; ridge regression performed best

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning models used pretreatment PET/CT radiomic features to estimate two-year event-free survival.
Test and result
Retrospective single-institution cohort split into training (231) and test (58), with stratified five-fold tuning; no external prospective validation.
Limitation / still unknown
No independent, prospective or clinical-impact evaluation is reported unless specified in the tested field.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s00330-022-09039-0

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Read the original full text, including author affiliations, Methods and Results; checked the first result-bearing version and active/archive catalog for same-result records..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.